Steven M. Haffner
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Diabetes Management and Research
- Cardiology and Cardiovascular Medicine top 0.05%
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 221
- Diabetes Treatment and Management 32
- Diabetes Management and Research 24
- Epidemiology 100
- Adipokines, Inflammation, and Metabolic Diseases 67
- Liver Disease Diagnosis and Treatment 30
- Co-authors
- Michael P. Stern (94 shared papers)Markku Laakso (23 shared papers)Ralph B. D’Agostino (52 shared papers)Seppo Lehto (6 shared papers)Kalevi Pyörälà (7 shared papers)Tapani Rönnemaa (8 shared papers)Ken Williams (31 shared papers)Andreas Festa (32 shared papers)
- Journals
- Diabetes Care (93 papers)Diabetes (75 papers)The Journal of Clinical Endocrinology & Metabolism (27 papers)Metabolism (22 papers)Circulation (21 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Steven M. Haffner
518 papers receiving 60.6k citations
Steven M. Haffner's Hit Papers
Peers
Comparison fields: 5 of 179
- Endocrinology, Diabetes and Metabolism 25.8k
- Cardiology and Cardiovascular Medicine 10.1k
- Physiology 8.2k
- Nephrology 2.3k
- Epidemiology 9.9k
Countries citing papers authored by Steven M. Haffner
This map shows the geographic impact of Steven M. Haffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Haffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Haffner more than expected).
Fields of papers citing papers by Steven M. Haffner
This network shows the impact of papers produced by Steven M. Haffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Haffner. The network helps show where Steven M. Haffner may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven M. Haffner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 519 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction Hit paper breakdown → | 1998 | 5389 |
| 2 | Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy Hit paper breakdown → | 2006 | 2299 |
| 3 | Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome Hit paper breakdown → | 2000 | 1986 |
| 4 | Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study Hit paper breakdown → | 2003 | 1240 |
| 5 | NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older Hit paper breakdown → | 2003 | 1218 |
| 6 | Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X) Hit paper breakdown → | 1992 | 1037 |
| 7 | Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes Hit paper breakdown → | 2012 | 937 |
| 8 | Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes Hit paper breakdown → | 2002 | 901 |
| 9 | Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus Hit paper breakdown → | 2002 | 751 |
| 10 | The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial Hit paper breakdown → | 2005 | 747 |
| 11 | The Homeostasis Model in the San Antonio Heart Study Hit paper breakdown → | 1997 | 701 |
| 12 | The Metabolic Syndrome as Predictor of Type 2 Diabetes Hit paper breakdown → | 2003 | 685 |
| 13 | Management of Dyslipidemia in Adults With Diabetes Hit paper breakdown → | 1998 | 647 |
| 14 | International Day for the Evaluation of Abdominal Obesity (IDEA) Hit paper breakdown → | 2007 | 574 |
| 15 | Cardiovascular Risk Factors in Confirmed Prediabetic Individuals Hit paper breakdown → | 1990 | 570 |
| 16 | Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease? Hit paper breakdown → | 2004 | 565 |
| 17 | Effect of Pioglitazone Compared With Glimepiride on Carotid Intima-Media Thickness in Type 2 Diabetes Hit paper breakdown → | 2006 | 546 |
| 18 | Homeostasis Model Assessment of Insulin Resistance in Relation to the Incidence of Cardiovascular Disease Hit paper breakdown → | 2002 | 536 |
| 19 | Impact of Diabetes on Mortality After the First Myocardial Infarction Hit paper breakdown → | 1998 | 529 |
| 20 | 2006 | 492 |
About Steven M. Haffner
Steven M. Haffner is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology, having authored 519 papers that have together received 64.1k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (221 papers), Adipokines, Inflammation, and Metabolic Diseases (67 papers), Lipoproteins and Cardiovascular Health (48 papers), Metabolism, Diabetes, and Cancer (41 papers), Diabetes Treatment and Management (32 papers), Liver Disease Diagnosis and Treatment (30 papers), Genetic Associations and Epidemiology (26 papers) and Diabetes Management and Research (24 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (25.8k citations), Cardiology and Cardiovascular Medicine (10.1k citations), Physiology (8.2k citations), Nephrology (2.3k citations) and Epidemiology (9.9k citations). Steven M. Haffner has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Michael P. Stern, Markku Laakso, Ralph B. D’Agostino, Seppo Lehto, Kalevi Pyörälà, Tapani Rönnemaa, Ken Williams, Andreas Festa, Helen P. Hazuda and Leena Mykkänen. Their work appears in journals such as Diabetes Care, Diabetes, The Journal of Clinical Endocrinology & Metabolism, Metabolism and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.